Fast Money's ASCO Biotech Trades
3151 views
Rate Now: 1 2 3 4

average rating: 0.00 / 0 ratings
Created by barrons2
DESCRIPTION:

Date updated:05-29-2008

The biotech sector is anticipating a big weekend for cancer drugs in the ASCO conference. What is the trade?

symbol name last price % change open
  • +
  • IMCL
    N/a
  • $69.67
  • 0.00
  • $69.67

We’re talking about lung cancer, explains CNBC Pharmaceuticals Reporter Mike Huckman. Look for headline-grabbing test results out of ImClone (IMCL).

People owning IMCL also tend to own: CSCOHPINTCMSFTNEXMSAAPL

TheStreet.com Rating: No Rating What is this?

  • +
  • DNA
    N/a
  • $80.43
  • 0.00
  • $80.43

Also keep an eye on Genetech (DNA), he says for two reasons 1) because the lung cancer data could have an impact on one of their drugs and Genentech should also deliver news on a breast cancer treatment.

People owning DNA also tend to own: AAPLDSCMGOOGXOMDWELXGLW

TheStreet.com Rating: No Rating What is this?

  • +
  • LLY
    Lilly Eli Co
  • $34.78
  • +0.75%
  • $34.49

As well as more details from Eli Lilly (LLY) on Alimta, its drug for lung cancer.

People owning LLY also tend to own: CCLXCVSGOOGGSHDJNJ

TheStreet.com Rating: C What is this?

  • +
  • CELG
    Celgene Corporati
  • $54.77
  • -0.71%
  • $N/A

In addition, Celgene (CELG) is another name to watch but keep in mind shares rallied when most of its study results were released two weeks ago.

People owning CELG also tend to own: GTIACIRADSTXNVARASHBNI

TheStreet.com Rating: C+ What is this?

  • +
  • BIIB
    Biogen Idec Inc
  • $52.84
  • -1.29%
  • $N/A

As well as Biogen (BIIB) and Elan (ELN).

People owning BIIB also tend to own: APOLBRK-BDELLELOSLXKSAFMSGTL

TheStreet.com Rating: B What is this?

  • +
  • ELN
    Elan Cp Plc Adr
  • $6.97
  • -2.52%
  • $7.11

As well as Biogen (BIIB) and Elan (ELN).

People owning ELN also tend to own: AMGNBWNGIASGITKG.OBBBYHOFFMOT

TheStreet.com Rating: No Rating What is this?

Portfolio not tracked!

Comments not available

ADD YOUR COMMENTS:

Must-See Charts: Ralcorp, Del Mo...

By Jonas Elmerraji Posted on Feb. 9, 2010 With stocks continuing to underwhelm in yesterday’s trading session, the attention is turning toward trading. After all, tec...

02.09.10 | 12:06 PM
This Week's 'Barron's' Roundup

By Roberto Pedone Posted on Feb. 8, 2010 Good Buys For Bad Times: This Barron’s article says with the U.S. economy expected to grow by only 3% in 2010, investors shou...

02.08.10 | 16:28 PM
Cramer's Take on Headline Stocks...

Posted on Feb. 8, 2010 Finance Professor Scott Rothbort will be answering questions on Stockpickr Answers on Monday, Feb. 8. Ask away! Regardless of why a stock is in...

02.08.10 | 14:45 PM
Rocket Stocks for the Week

By Jonas Elmerraji Posted on Feb. 8, 2010 Finance Professor Scott Rothbort will be answering questions on Stockpickr Answers on Monday, Feb. 8. Ask away! Investor an...

02.08.10 | 08:39 AM
more articles
Nymph's Trading Daily Trading Diary
04.13.09 | 01:10 AM From author Trading Nymph
Cartoon Thread
11.15.07 | 20:31 PM From author Peter near Matanzas Inlet
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
Everything Goldman Sachs. The in...
01.11.10 | 12:54 PM From author DogBones
more forums
Q. I can see where this below is he...
02.09.10 | 23:30 PM Asked by π

A. A war between China and the USA appeases
the masses on both sides in many ways...
and solves about 25 differnt issues and
problems we are facing now as nation and
as future global participant and
population control...a good "dust
up" to thin the herd...so to speak

today 's lists
TheStreet Ratings' Downgrades

TheStreet Ratings provides exclusive stock, ETF and mutual fund ratings and commentary based on award-winning, proprietary tools. Its safety first approach to investing aim... more

Top Open-Market Insider Buys

Below is the list of the top open-market insider buys filed at the SEC on Feb. 8, 2010. more

Earnings Announcements

Here is a list of some of the companies that will report earnings on Wednesday, Feb. 10, 2010. For some of the companies below, we provide average EPS estimates from analy... more